Preview

Oncohematology

Advanced search

Selective correction of haemostatic defects in children with acute leukemia and malignant neoplasms

https://doi.org/10.17650/1818-8346-2009-0-4-22-26

Abstract

Treatment of children with acute leukemia or other malignant neoplasm can be complicated with bleeding, caused by decreased vitamin K-dependent coagulations factors. Administration of prothrombin complex concentrate seems more convenient than transfusion of fresh frozen plasma with regard to volume overload and speed of administration. Recombinant rVIIa has been successfully used in patients with uncontrolled bleeding during surgery, including patients with thrombocytopenia.

About the Authors

V. V. Dmitriev
Republic Centre for Paediatric Oncology and Haematology
Belarus

Minsk



I. A. Dunaev
Republic Centre for Paediatric Oncology and Haematology
Belarus

Minsk



References

1. Buchanan G.R. Hematologic supportive care of the pediatric cancer patient. In: Pediatric oncology. P.A. Pizzo, D.G. Poplack. J.B.: Lippincott Company, 1993. p. 980—1.

2. Sutor A.H., Niemeyer C., Sauter S. et al. Gerinnungsveranderungen bei Behandlung mit den Protokollen ALLBFM-90 und NHL-BFM-90. Klinische Padiatrie 1992;204(4):264—73.

3. Esmon C.T. Regulation of blood coagulation. Biochim Biophys Acta 2000;1477:349—60.

4. Varadi K., Negrier C., Berntorp E. et al. Monitoring the bioavailability of FEIBA with a thrombin generation assay. J Thromb Haemost 2003;1(11):2374—80.

5. Turecek P.L., Varadi K., Schwarz H.P. Update on mechanism of action and future of activated prothrombin complex concentrates. Cur Hematol Rep 2004;3:331—7.

6. Johannessen M., Nielsen G., Nordfang O. Comparison of the factor VII:C clot analysis and a modified activated factor VII analysis for monitoring factor VII activity in patients treated with recombinant activated factor VII. Blood Coagul Fibrinol 2000;11(Suppl 1):159—64.

7. Aldouri M. The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients. Pathophysiol Haemost Thromb 2002;32(Suppl 1):41—6.

8. Regazzoni C.J., Khoury M., Irrazabal C. et al. Neutropenia and the development of the systemic inflammatory response syndrome. Intensive Care Med 2003;29(1):135—8.

9. Andrew M., Vegh P., Johnston M. et al. Maturation of the hemostatic system during childhood. Blood 1992;80(8):1998— 2005.

10. Octermann H., Haetel S., Knaub S. Pharmacokinetics of Beriplex P/N prothrombin complex concentrate in healthy volunteers. Thromb Haemost 2007;98:790—7.

11. Youssef W.I., Salazar F., Dasarathy S. et al. Role of fresh frozen plasma infusion in correction of coagulopathy of chronic liver disease: A dual phase study. Am J Gastroenterol 2003;98(6):1391—4.

12. Dara S.I., Rana R., Afessa B. et al. Fresh frozen plasma transfusion in critically ill medical patients with coagulopathy. Crit Care Med, 2005;33:2667—71.


Review

For citations:


Dmitriev V.V., Dunaev I.A. Selective correction of haemostatic defects in children with acute leukemia and malignant neoplasms. Oncohematology. 2009;(4):22-26. (In Russ.) https://doi.org/10.17650/1818-8346-2009-0-4-22-26

Views: 169


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1818-8346 (Print)
ISSN 2413-4023 (Online)